索利德生物科学

最新新闻

• Truist Financial Initiates Solid Biosciences(SLDB.US) With Buy Rating, Announces Target Price $20
  \u5e02\u573a\u8d44\u8baf · 2026/8/21
• Piper Sandler Maintains Solid Biosciences(SLDB.US) With Buy Rating, Maintains Target Price $18
  \u5e02\u573a\u8d44\u8baf · 2026/9/30
• 评级变动
  Citi Maintains Solid Biosciences(SLDB.US) With Buy Rating, Maintains Target Price $14
  \u5e02\u573a\u8d44\u8baf · 2026/9/11
• Cantor Fitzgerald Maintains Solid Biosciences(SLDB.US) With Buy Rating, Maintains Target Price $26
  \u5e02\u573a\u8d44\u8baf · 2026/9/16
• 评级变动
  William Blair Maintains Solid Biosciences(SLDB.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/8/7
• 评级变动
  H.C. Wainwright Remains a Buy on Solid Biosciences (SLDB)
  TipRanks · 2026/5/15
• Leerink Partners Initiates Solid Biosciences(SLDB.US) With Buy Rating, Announces Target Price $20
  \u5e02\u573a\u8d44\u8baf · 2026/9/16
• 评级变动
  Cantor Fitzgerald Maintains Solid Biosciences(SLDB.US) With Buy Rating, Maintains Target Price $16
  \u5e02\u573a\u8d44\u8baf · 2026/5/13
• 评级变动
  J.P. Morgan Maintains Solid Biosciences(SLDB.US) With Buy Rating, Maintains Target Price $11
  \u5e02\u573a\u8d44\u8baf · 2026/8/11
• 评级变动
  J.P. Morgan Maintains Solid Biosciences(SLDB.US) With Buy Rating, Cuts Target Price to $11
  \u5e02\u573a\u8d44\u8baf · 2026/5/23
• 评级变动
  H.C. Wainwright Maintains Solid Biosciences(SLDB.US) With Buy Rating, Maintains Target Price $20
  \u5e02\u573a\u8d44\u8baf · 2026/5/15
• 评级变动
  Cantor Fitzgerald Maintains Solid Biosciences(SLDB.US) With Buy Rating, Raises Target Price to $26
  \u5e02\u573a\u8d44\u8baf · 2026/8/27
• 评级变动
  H.C. Wainwright Maintains Solid Biosciences(SLDB.US) With Buy Rating, Raises Target Price to $25
  \u5e02\u573a\u8d44\u8baf · 2026/6/3
• 评级变动
  RBC Capital Initiates Solid Biosciences(SLDB.US) With Buy Rating, Announces Target Price $18
  \u5e02\u573a\u8d44\u8baf · 2026/9/16
• 公司公告
  Solid Biosciences: Solid Biosciences Inc. - Reverse Split Option Symbol: SLDB New Symbol: SLDB1
  OCC · 2022/10/27
• 评级变动
  J.P. Morgan Reaffirms Their Buy Rating on Solid Biosciences (SLDB)
  TipRanks · 2026/5/23
• 评级变动
  Chardan Capital Maintains Solid Biosciences(SLDB.US) With Buy Rating, Maintains Target Price $15
  \u5e02\u573a\u8d44\u8baf · 2026/5/14
• H.C. Wainwright Maintains Solid Biosciences(SLDB.US) With Buy Rating, Maintains Target Price $25
  \u5e02\u573a\u8d44\u8baf · 2026/9/14
• 评级变动
  Needham Maintains Solid Biosciences(SLDB.US) With Buy Rating, Maintains Target Price $19
  \u5e02\u573a\u8d44\u8baf · 2026/8/7
• 评级变动
  Wedbush Maintains Solid Biosciences(SLDB.US) With Buy Rating, Maintains Target Price $16
  \u5e02\u573a\u8d44\u8baf · 2026/5/18

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。